TAVR

What Is TAVR?

Transcatheter aortic valve replacement, commonly abbreviated TAVR, is a minimally invasive procedure used to replace a diseased aortic valve without the need for open heart surgery. Rather than removing the damaged valve entirely, physicians deliver a new, replacement valve through a catheter and position it directly inside the existing valve.¹

TAVR was developed primarily to treat severe aortic stenosis, a condition in which the aortic valve becomes narrowed and stiff, restricting blood flow out of the heart and forcing the heart to work considerably harder with every beat. Left untreated, severe symptomatic aortic stenosis carries a poor prognosis, making timely valve replacement an important treatment goal.¹

The procedure was first approved in 2011 for patients considered too high risk to safely undergo traditional open heart surgery. Since that initial approval, TAVR has expanded considerably, now available to patients across a broad range of surgical risk, including many considered low risk, reflecting the accumulating evidence supporting its safety and effectiveness.¹

TAVR has transformed the management of severe aortic stenosis by providing a minimally invasive alternative to surgical aortic valve replacement.
National Center for Biotechnology Information

How Does TAVR Work?

The replacement valve used in TAVR is compressed to fit inside a narrow catheter, allowing it to be delivered through a blood vessel rather than requiring an incision into the chest. Most commonly, the catheter is inserted through the femoral artery in the leg, though alternative access points can be used when the femoral approach is not suitable.¹

Once the catheter reaches the diseased aortic valve, the new valve is carefully positioned within it and then expanded into place. Depending on the specific device used, expansion occurs either through inflation of a balloon or through the valve’s own self expanding frame, pushing the old, diseased valve leaflets outward against the walls of the aortic root to make room for the new valve.²

The new valve begins functioning almost immediately upon deployment, taking over the work of regulating blood flow out of the heart. Imaging throughout the procedure allows the physician to confirm accurate positioning and proper valve function before the catheter is withdrawn.²

Who Needs TAVR?

Candidates for TAVR most commonly have severe, symptomatic aortic stenosis confirmed through echocardiography, along with symptoms such as shortness of breath, chest pain, or fainting spells that significantly affect daily life.¹

A multidisciplinary heart team, typically including cardiologists and cardiac surgeons, evaluates each candidate to determine whether TAVR or traditional surgical valve replacement represents the better option, taking into account surgical risk, valve anatomy, and overall health.³

While TAVR was initially reserved for patients at high or extreme surgical risk, expanded approval now allows appropriately selected intermediate and low risk patients to choose TAVR as well, particularly those who value a shorter recovery period and wish to avoid the more invasive nature of open heart surgery.¹

The Procedure

TAVR is typically performed under general anesthesia or moderate sedation in a specialized catheterization laboratory equipped with advanced imaging technology. A catheter is inserted through a blood vessel, most often in the groin, and carefully guided toward the heart under continuous imaging guidance.²

Once positioned at the level of the diseased aortic valve, the replacement valve is deployed, expanding either through balloon inflation or self expansion depending on the device selected. The entire procedure typically takes one to two hours, considerably shorter than traditional open heart valve replacement surgery.¹

Because TAVR avoids opening the chest and does not require stopping the heart, as conventional surgery does, most patients recover more quickly, often leaving the hospital within a few days rather than the week or more typically required following open heart surgery.³

Risks and Complications

Vascular complications at the catheter insertion site are among the more common issues associated with TAVR, given that the procedure relies on accessing a blood vessel, most often in the groin, to deliver the replacement valve to the heart.⁴

TAVR carries a higher rate of permanent pacemaker implantation compared with surgical valve replacement, since the procedure can occasionally disrupt the heart’s electrical conduction system near the new valve. Paravalvular leak, in which blood flows around rather than through the new valve, is another recognized complication more common with TAVR than with surgery.⁴

Stroke, though relatively uncommon, remains a serious potential complication, since manipulating a catheter near the aortic valve carries some risk of dislodging debris that could travel to the brain. Overall complication rates have declined considerably as device technology and procedural technique have improved over the years since TAVR was first introduced.⁴

Life After TAVR

Most patients experience meaningful symptom improvement within days to weeks of the procedure, with reduced shortness of breath and improved exercise tolerance reflecting the restored blood flow through the newly functioning valve.³

Antiplatelet medication is generally prescribed for a period following the procedure to reduce the risk of clot formation on the new valve, and regular follow up appointments with echocardiography allow the care team to confirm the valve continues functioning properly over time.¹

Most patients return to normal daily activities within a few weeks, a considerably faster recovery timeline than typically seen after traditional open heart valve surgery, which often requires a longer period of activity restriction during the healing process.³

Outcomes and Effectiveness

Clinical trials comparing TAVR with traditional surgical valve replacement in low risk patients have found a meaningful reduction in short term mortality favoring TAVR, along with shorter hospital stays and faster recovery.⁵

At intermediate term follow up of around five years, survival between TAVR and surgical replacement tends to become more similar, suggesting that the early advantage seen with TAVR may narrow over a longer time horizon, though research in this area continues to evolve as longer term data accumulates.⁵

Traditional surgical valve replacement is still generally considered to offer superior long term durability in select patient populations, particularly younger patients and those with certain valve anatomy such as bicuspid aortic valves, making the choice between TAVR and surgery a decision that depends heavily on individual patient factors.⁶

Why Visual Communication Matters for TAVR

Explaining how a folded, catheter delivered valve can expand and take over the function of a diseased aortic valve, all without opening the chest, is genuinely difficult without clear visuals. Patients facing a valve diagnosis often want to understand exactly how this technology works before deciding between TAVR and traditional surgery.¹

Device manufacturers, structural heart programs, and patient education teams rely on precise illustration and animation to explain candidacy, procedural steps, and the tradeoffs between transcatheter and surgical valve replacement.

• Illustrating how a compressed replacement valve is delivered through a catheter and expanded into place
• Animating the difference between balloon expandable and self expanding valve designs
• Comparing TAVR and surgical aortic valve replacement for patient education
• Explaining how the new valve displaces diseased leaflets against the aortic root
• Visualizing recovery timelines and follow up care after the procedure
• Supporting clinical training on patient selection and complication management

How Biotic Artlab Supports TAVR Communication

We partner with structural heart device manufacturers, cardiac surgery programs, and healthcare organizations to create precise, engaging visuals that make TAVR understandable for patients, clinicians, and industry audiences alike.

• Custom 3D animations of catheter delivery and transcatheter valve deployment
• Detailed illustrations comparing TAVR with traditional surgical valve replacement
• Patient education materials explaining candidacy, procedure, and recovery
• Clinical training content for structural heart and cardiac catheterization teams
• Regulatory and investor facing visuals explaining device mechanism of action
• Conference presentations and marketing materials for structural heart audiences

Frequently Asked Questions

Is TAVR open heart surgery?

No. TAVR is a minimally invasive, catheter based procedure that avoids opening the chest and does not require stopping the heart, distinguishing it from traditional surgical aortic valve replacement.¹

How long does recovery from TAVR take?

Most patients leave the hospital within a few days and return to normal daily activities within a few weeks, considerably faster than the recovery typically associated with open heart valve surgery.³

Is TAVR only for high risk surgical patients?

No longer. While TAVR was initially approved only for patients too high risk for surgery, approval has since expanded to include intermediate and low risk patients as well, based on accumulating evidence of safety and effectiveness across risk categories.¹

What is the biggest risk specific to TAVR compared to surgery?

TAVR carries a higher rate of permanent pacemaker implantation and paravalvular leak compared with surgical valve replacement, while surgery carries higher rates of bleeding, kidney injury, and new onset atrial fibrillation.⁴

Does the replacement valve last as long as a surgical valve?

Long term durability data continues to accumulate. Traditional surgical valve replacement is still generally considered to offer superior long term durability in certain patient groups, which is one factor considered when choosing between the two approaches.⁶

Who decides whether a patient should have TAVR or surgery?

A multidisciplinary heart team, typically including cardiologists and cardiac surgeons, evaluates each patient’s specific anatomy, overall health, and surgical risk to recommend the most appropriate treatment option.³

Have a Project in Mind? Contact Us.

If you are developing training materials, patient education content, or marketing visuals related to TAVR or structural heart interventions, our team can help bring the science to life with precision and clarity. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information, StatPearls. Transcatheter Aortic Valve Replacement.
2. National Center for Biotechnology Information. Effect of Balloon Expandable Transcatheter Aortic Valve Replacement Positioning, A Patient Specific Numerical Model.
3. National Center for Biotechnology Information. Transcatheter Aortic Valve Replacement, Current Status and Future Indications.
4. National Center for Biotechnology Information. Transcatheter Aortic Valve Replacement, Past, Present, and Future.
5. National Center for Biotechnology Information. Short and Intermediate Term Outcomes of Transcatheter Aortic Valve Replacement in Low Risk Patients, A Meta Analysis and Systematic Review.
6. National Center for Biotechnology Information. Comparison of Short and Long Term Outcomes Between Transcatheter and Surgical Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.